CBRE Group, Inc.
CBRE - NYSE - $142.57 ▲ +%1.80
-
Earnings Tue 4 Aug

CBRE opens the
books on Tuesday evening.

5 analysts' median target is $180[FMP target], stock is $143, +25.9% upside potential. After Q1 +42.5% EPS beat[FMP earnings], the stock moved -0.7%.

↓ summary below
Quick Take - in 40 seconds
B+
BUY Council 5/6 - Moonshot 40

B+ = MoonshotScore 40[9-pillar formula] + Council 5/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].

Q1 consensus: revenue $10.4B[FMP est], EPS $1.49[FMP est]. 8 consecutive quarters of beat[FMP earnings].

Detailed analysis below ↓
$1.49 EPS Estimate Last year $1.61 - +25% YoY YoY
8 Beat Streak Expectations beaten consecutively for the last 8 quarters

Q1 EPS +42.5% beat[FMP] but the stock -0.7% D+1[FMP D+1]. Emma Giamartino promised $81.0M CapEx + a sequential decline in Q1 during the Q1 earnings call[Emma Giamartino capex transcript].

Watchlist

5 metrics stand out this quarter.

$7.60 Expectation / Guide

Eps Guidance Increase

eps_guidance_increase

CBRE is raising its full year core EPS expectations for 2026 to a range of $7.60 to $7.80, driven by strong Q1 performance and momentum in infrastructure services.

"As Bob indicated, we now expect full year core EPS of $7.60 to $7.80, up from $7.30 to $7.60, previously. The increase is driven by our outperformance in the first quarter and early part of the second quarter, momentum in our infrastructure services-related businesses and strong pipelines across our company."

- Emma Giamartino, CFO - Q1 FY26 Earnings Call - April 23, 2026
$1.7 Investor Focus

Infrastructure Services Growth

infrastructure_services_growth

CBRE's dedicated critical infrastructure services business line is expected to grow in excess of 60% this year.

"Revenue in this business line totaled $1.7 billion in 2025 and $580 million in the first quarter and is expected to grow in excess of 60% this year."

- Robert Sulentic, CEO - Q1 FY26 Earnings Call - April 23, 2026
22% Investor Focus

Transactional Business Growth

transactional_business_growth

CBRE's Transactional Businesses achieved their highest growth rate of the current cycle at 22%, reflecting their market leadership in sales, leasing, financing, and real estate development.

"Simultaneously, our Transactional Businesses achieved their highest growth rate of the current cycle at 22%, reflecting our strategy to maintain and extend our market leadership position in sales, leasing, financing, and real estate development."

- Robert Sulentic, CEO - Q1 FY26 Earnings Call - April 23, 2026
23% Investor Focus

Boe Sop Growth

boe_sop_growth

Building Operations & Experience (BOE)'s SOP increased 23%, with operating leverage driven by an amortization cost reclassification. Excluding this change, SOP growth was in line with revenue growth as expected.

"BOE's SOP increased 23%, with operating leverage driven by an amortization cost reclassification. Excluding this change, SOP growth was in line with revenue growth as expected."

- Emma Giamartino, CFO - Q1 FY26 Earnings Call - April 23, 2026
35% Investor Focus

Advisory Sop Growth

advisory_sop_growth

Advisory Services delivered strong operating leverage, with SOP growing 35%.

"Advisory SOP grew 35%, delivering strong operating leverage."

- Emma Giamartino, CFO - Q1 FY26 Earnings Call - April 23, 2026

Stock Expert AI - Methodology

Do our 9 pillars, 7 perspectives, and Munger lens point in the same direction?

MoonshotScore 40 / 100

9-pillar methodology. Price Momentum and News Sentiment strong. Gross Margin weak.

How is it calculated? ->
Revenue Growth4.0Q1 vs Q2: moderate growth (+7.9%)
Gross Margin2.0Q1: low margin (17.6%, capital-intensive or commodity)
Operating Leverage0.0op margin weak (4.9%, under pressure)
Cash Runway3.0FCF negative ($-0.9B, external financing needed)
R&D Intensity3.0low R&D investment (0.0%, weak innovation)
Price Momentum7.0RSI 47.5 balanced, 50d above
News Sentiment9.0strong buy consensus (92%)
Council Score 5 / 6 Bullish

6 investor frameworks. 5 bullish (Ray Dalio, Ken Griffin, Klarman, Buffett, Munger), 0 bearish (none), 1 neutral (Jim Simons).

How is it calculated? ->
Ray Dalio macro - target upside +25.9%
Ken Griffin flow - 50d MA above
Jim Simons quant - RSI 47
Klarman value - target upside +25.9%
Buffett quality - ROE score 5/5
Munger valuation - target upside +25.9%
Munger's Mindset character & balance sheet lens
Undervalued

Quality business, discounted price.

How is it calculated? ->
Financial HealthModerate
Margin of SafetyStrong
Interest CoverageAdequate
ROIC vs WACCHealthy
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
47.5 RSI 47.5 balanced, 50d above
MACD
+1.20 price above 50d - support positive
50d MA
$141 stock 1.2% above - short-term support
200d MA
$154 stock 7.6% below - long-term pressure
Volume (10d)
-44% decrease - low participation
Resistance
$180
Analyst median target - upgrade trigger if broken
Current
$143
Pre-earnings position
Support
$131
Invalidation - close below this is a technical breakdown
Pattern
Range
$131-$180 band - earnings breakout/breakdown trigger

Past Performance

CBRE beat expectations in the last 8 quarters.

BEAT
Q2 FY25
$1.19 vs $1.07 est - -0.4%
BEAT
Q3 FY25
$1.61 vs $1.46 est - -0.8%
BEAT
Q4 FY25
$2.73 vs $2.68 est - +4.4%
BEAT
Q1 FY26
$1.61 vs $1.13 est - -0.7%

Q1 (April 23, 2026): EPS $1.61 vs $1.13 est[FMP], +42.5% beat. D+1 movement: -0.7%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.

Three scenarios: what could happen?

EPS < $1.45 (no guidance)

Q1: EPS $1.61 vs $1.13 beat[FMP], stock -0.7% D+1[FMP].

Backlog concentration

No RPO/backlog concentration disclosed in Q1 earnings call.

CapEx shock

Q1 CapEx $81.0M[FMP cashflow]. Q1 op margin 4.9%[FMP op margin] - this level in Q1 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q1 EPS > $1.49 + CapEx discipline
Threshold: EPS > $1.49[FMP est].
Target: Break above median target $180[FMP target]; high target $185[FMP] upper bound.
Scenario B - In-Line
EPS approx $1.49 + CapEx < $81.0M
Threshold: EPS approx $1.49[FMP est], Q1 CapEx < $81.0M[FMP].
Target: Consolidation in the band between current $143[FMP] and median $180[FMP].
Scenario C - Miss
EPS < $1.45 or CapEx >= $81.0M
Threshold: EPS < $1.45[FMP estx0.97].
Target: Current $143 below SMA200 $154[FMP], if rejection continues, $131[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.

Market Outlook

What do 5 analysts say?

Wall Street Consensus
$180
12-month median target price (+25.9% upside potential)
12
BUY
1
HOLD
0
SELL
Risk Management
$131
Invalidation level - critical support threshold
$141 - 50-day MA (above, +1.2%)
$154 - 200-day MA (below, -7.6%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - CBRE Q1 FY27
B+

You read it in 5 minutes. When the numbers come out on Tuesday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Tuesday evening. The framework is ready on this page: Q1 EPS threshold $1.49[FMP], CapEx threshold "below $81.0M"[Emma Giamartino]. Two anchors, three scenarios.

Comparison Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore 9-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Try Pro free for 14 days CBRE dossier ->

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

Aug 4, 2026EARNINGSQ1 FY27 results (after market close) + earnings call
Aug 5, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Sep 18, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Nov 4, 2026EARNINGSQ2 FY27 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the CBRE earnings preview cover?

This CBRE (CBRE) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in CBRE earnings?

Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.